3T is a company specializing in immunotherapy, focusing on the advancement of innovative treatments for solid tumors and other immune-related conditions across a wide range of patients. By harnessing the immune system's ability to identify, target, and eradicate cancerous cells, 3T's technology is propelling the progress of next-generation therapies that offer the potential for enhanced safety, efficacy, and possibly even cures for challenging cancers.